Home > R&D > Research & Development > New Drug Development
   
   
 
 
 
 
 
 
 
 
 
Untitled Document
 
 

Jin Yang Pharmaceutical Co. Ltd and Bioobesity signed an Agreement for Joint Research and Development of therapeutic agents for obesity Jin Yang Pharmaceutical Co. Ltd (President & CEO : Jae-Joon, Choi) and Bioobesity Co. Ltd. (Representative Director : Professor Gim Jongyeon), a bioventure company established by professors of the Medical College of Yeungnam University, signed an Agreement for Joint Research and Development of therapeutic agents for obesity on 7 February 2002.

Through this agreement, Jin Yang Pharmaceutical can take part in a certain share of the venture company, and at the same time, it will own patent rights as well as production and marketing rights. Bioobesity Co. Ltd. is a promising venture company which has state of the art High Throughput Screening technology and is carrying out research and development of therapeutic agents for diabetes, alopecia, osteoporosis and fracture in addition to therapeutic agents for obesity by utilizing specialized technologies.

In especial, it also places great stress on the research of therapeutic agents for the next generation by means of finding out the mechanism of pathogen through proteome research which is making its appearance as a core of future biotechnology as a follow-up research of genome research. Bioobesity Co. Ltd. was established in August 2001 and now it owns advanced experiment equipment and state of the art technology as well as excellent research personnel, and that is why it is looked upon as a promising venture company with outstanding and creative research and development capacity (various research items).